Nikhil C Munshi Selected Research

Nikhil C Munshi Research Topics

Disease

207	Multiple Myeloma 05/2024 - 01/2002
108	Neoplasms (Cancer) 04/2024 - 07/2002
11	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 10/2003
10	Waldenstrom Macroglobulinemia (Macroglobulinemia) 09/2022 - 07/2004
6	Genomic Instability 11/2023 - 01/2018
6	Adenocarcinoma 11/2022 - 05/2004
6	Residual Neoplasm 01/2020 - 07/2013
5	Chromosomal Instability (Chromosome Stability) 01/2023 - 01/2002
5	Colorectal Neoplasms (Colorectal Cancer) 11/2022 - 08/2012
5	Lymphoma (Lymphomas) 01/2022 - 07/2006
5	Carcinogenesis 01/2021 - 02/2011
5	Paraproteinemias (Monoclonal Gammopathy) 01/2020 - 03/2007
4	Colonic Neoplasms (Colon Cancer) 11/2022 - 01/2014
4	Plasmacytoma 09/2007 - 09/2002
3	Breast Neoplasms (Breast Cancer) 11/2022 - 03/2011
3	Infections 02/2022 - 05/2002
3	Fatigue 01/2022 - 08/2010
3	Peripheral Nervous System Diseases (PNS Diseases) 01/2018 - 07/2009
3	Monoclonal Gammopathy of Undetermined Significance 01/2018 - 10/2009
3	Bone Diseases (Bone Disease) 01/2016 - 07/2009
3	Leukemia 01/2016 - 03/2007
3	Bone Resorption 08/2012 - 10/2007
3	Human Influenza (Influenza) 03/2011 - 06/2003

Drug/Important Bio-Agent (IBA)

37	Bortezomib (Velcade)FDA Link 03/2024 - 09/2002
27	Lenalidomide (CC 5013)FDA Link 10/2023 - 12/2004
22	Dexamethasone (Maxidex)FDA LinkGeneric 10/2023 - 02/2002
21	Proteasome InhibitorsIBA 03/2024 - 10/2002
17	Proteins (Proteins, Gene)FDA Link 03/2024 - 05/2002
16	AntigensIBA 04/2024 - 06/2003
13	Interleukin-6 (Interleukin 6)IBA 08/2016 - 01/2002
12	CytokinesIBA 03/2024 - 01/2002
10	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2024 - 01/2002
10	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 03/2003
9	Monoclonal AntibodiesIBA 03/2024 - 07/2005
9	B-Cell Maturation AntigenIBA 03/2024 - 07/2006
9	Chimeric Antigen ReceptorsIBA 01/2023 - 01/2021
9	MicroRNAs (MicroRNA)IBA 01/2020 - 10/2010
9	Thalidomide (Thalomid)FDA Link 11/2019 - 06/2002
8	Melphalan (Alkeran)FDA LinkGeneric 05/2024 - 07/2002
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 10/2007
8	NF-kappa B (NF-kB)IBA 04/2010 - 08/2002
7	Immunomodulating AgentsIBA 11/2021 - 04/2009
6	Histone Deacetylases (Histone Deacetylase)IBA 04/2024 - 10/2003
6	Histone Deacetylase InhibitorsIBA 04/2024 - 05/2003
6	idecabtagene vicleucelIBA 01/2023 - 01/2021
6	Immunoglobulin G (IgG)IBA 11/2014 - 07/2005
5	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 03/2024 - 01/2003
5	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 10/2023 - 05/2005
5	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2023 - 10/2002
5	Long Noncoding RNAIBA 01/2023 - 01/2018
5	Immunoconjugates (Immunoconjugate)IBA 11/2021 - 07/2004
5	Peptides (Polypeptides)IBA 01/2019 - 06/2012
4	Immunoglobulins (Immunoglobulin)IBA 01/2023 - 01/2006
4	UbiquitinIBA 01/2023 - 08/2017
4	Immunoglobulin M (IgM)IBA 11/2021 - 12/2008
4	EnzymesIBA 08/2017 - 10/2003
4	Messenger RNA (mRNA)IBA 10/2015 - 08/2008
4	perifosineIBA 04/2010 - 05/2006
4	Cytotoxins (Cytolysins)IBA 04/2009 - 07/2004
4	GlucocorticoidsIBA 12/2007 - 06/2005
4	Insulin-Like Growth Factor I (IGF-1)IBA 02/2003 - 08/2002
3	OligonucleotidesIBA 03/2024 - 02/2002
3	dacetuzumabIBA 03/2024 - 04/2004
3	Insulin (Novolin)FDA Link 03/2024 - 08/2002
3	Small Interfering RNA (siRNA)IBA 11/2023 - 07/2005
3	Alkylating AgentsIBA 01/2023 - 07/2007
3	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2023 - 08/2005
3	RNA (Ribonucleic Acid)IBA 12/2022 - 10/2003
3	pomalidomideIBA 11/2021 - 03/2013
3	trans-crotonin (CTN)IBA 01/2020 - 01/2018
3	LigandsIBA 01/2019 - 07/2006
3	CD40 Ligand (CD40L)IBA 01/2018 - 07/2005
3	Transcription Factors (Transcription Factor)IBA 01/2017 - 02/2011
3	Zoledronic Acid (Zometa)FDA Link 11/2014 - 09/2009
3	Sirolimus (Rapamycin)FDA Link 04/2010 - 12/2004
3	Antineoplastic Agents (Antineoplastics)IBA 04/2010 - 09/2002
3	AntibodiesIBA 01/2008 - 01/2004
3	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 10/2007 - 06/2005
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2007 - 07/2006
3	ParaproteinsIBA 08/2005 - 07/2004
3	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2005 - 07/2002
2	LNA-i-miR-221IBA 05/2024 - 03/2016
2	citarinostatIBA 04/2024 - 01/2018
2	CalreticulinIBA 03/2024 - 01/2021
2	telomerase RNA (bTR)IBA 03/2024 - 10/2003
2	phosphoramidic acidIBA 03/2024 - 10/2003
2	GRN163IBA 03/2024 - 10/2003
2	Cyclophilins (Cyclophilin)IBA 01/2024 - 06/2015
2	Phosphotransferases (Kinase)IBA 11/2023 - 12/2004
2	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2021
2	A-Form DNA (A-DNA)IBA 01/2023 - 11/2022
2	Recombinases (Recombinase)IBA 11/2022 - 01/2020
2	venetoclaxIBA 01/2022 - 11/2021
2	VaccinesIBA 01/2022 - 07/2013

Therapy/Procedure

70	Therapeutics 10/2023 - 08/2002
12	Drug Therapy (Chemotherapy) 03/2024 - 05/2004
12	Immunotherapy 03/2024 - 06/2003
7	Stem Cell Transplantation 01/2022 - 02/2007
4	Transplantation 01/2022 - 03/2007
3	Chemoprevention 12/2010 - 05/2004